HIMS & Hers Health Stock on Monday booked a record deficit after Novo Nordisk, the producer of the weight-loss drug vegovi, stated that it was ending cooperation with the telehaalth company after less than two months of the onset.
Source link
HIMS & Hers Health Stock on Monday booked a record deficit after Novo Nordisk, the producer of the weight-loss drug vegovi, stated that it was ending cooperation with the telehaalth company after less than two months of the onset.
Source link
